Parsons Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$28.3M |
| 2 |
Microsoft
MSFT
|
+$26.5M |
| 3 |
JPMorgan Chase
JPM
|
+$23.4M |
| 4 |
NextEra Energy
NEE
|
+$19.5M |
| 5 |
Emerson Electric
EMR
|
+$16.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Relmada Therapeutics
RLMD
|
+$2.05M |
| 2 |
CVS Health
CVS
|
+$2.04M |
| 3 |
Rio Tinto
RIO
|
+$1.75M |
| 4 |
Devon Energy
DVN
|
+$1.73M |
| 5 |
Nike
NKE
|
+$1.46M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.37% |
| 2 | Financials | 13.48% |
| 3 | Industrials | 11.26% |
| 4 | Healthcare | 9.64% |
| 5 | Consumer Discretionary | 7.06% |
Similar funds
Parsons Capital Management's Q4 2024 Portfolio in Review
As of Q4 2024, Parsons Capital Management held 459 positions worth $1.84B, up 17% from $1.58B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Parsons Capital Management deployed $267M of net new capital in Q4 2024, opening 14 new positions and adding to 139 existing holdings. Its largest new stake was VanEck IG Floating Rate ETF: 254,121 shares worth $6.47M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Relmada Therapeutics, an estimated $2.05M trimmed.
- Parsons Capital Management's largest Q4 2024 buy was VanEck IG Floating Rate ETF: 254,121 shares worth $6.47M.
- Parsons Capital Management added most to Apple in Q4 2024, an estimated $28.3M increase.
- Parsons Capital Management's biggest Q4 2024 reduction was Relmada Therapeutics, cutting an estimated $2.05M.
- Parsons Capital Management fully exited CVS Health in Q4 2024, selling an estimated $2.04M.
- Parsons Capital Management's ten largest holdings make up 35% of its $1.84B portfolio in Q4 2024.
- Parsons Capital Management opened 14 new positions and closed 18 in Q4 2024.
- Parsons Capital Management's portfolio value rose 17% quarter-over-quarter to $1.84B.
Based on Parsons Capital Management's 13F filing for Q4 2024, filed 22 Jan 2025.